Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2026-01-01 @ 3:36 AM
Study NCT ID:
NCT00078234
Status:
COMPLETED
Last Update Posted:
2011-11-07
First Post:
2004-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia
Sponsor:
Genta Incorporated
Organization: